Clinical Trials Insight: 700032832

Trial Profile

Clinical Trials Insight: 700032832

Phase of Trial: Phase II

Latest Information Update: 22 Apr 2008

At a glance

  • Drugs BHT 3009 (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Sponsors Bayhill Therapeutics
  • Most Recent Events

    • 22 Apr 2008 New trial record.
    • 17 Apr 2008 The trial is expected to commence later in 2009, according to a Bayhill Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top